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To assess the impact of preventive measures by the food industry, we ana-
lyzed food monitoring data as well as trends in the incidence of listeriosis
estimated through three independent sources: the National Reference Cen-
ter of Listeriosis; a laboratory-based active surveillance network; and two
consecutive nationwide surveys of public hospital laboratories. From 1987
to 1997, the incidence of listeriosis decreased by an estimated 68%. A sub-
stantial reduction in the proportion of Listeria monocytogenes-contaminated
products was observed at the retail level. The temporal relationship
between prevention measures by the food industry, reduction in L. monocy-
togenes-contaminated foodstuffs, and reduction in listeriosis incidence sug-
gests a causal relationship and indicates that a substantial part of the
reduction in illness is related to prevention efforts.
Although rare, invasive listeriosis is an infection of pub-
lic health concern because of its severity, with a case-fatality
rate evaluated at 20%-30%, the possible sequelae, and its
potential to cause epidemics. In 1981, the investigation of an
outbreak of listeriosis in Canada demonstrated for the first
time that human listeriosis could be caused by transmission
of  Listeria monocytogenes through contaminated foods, in
this case coleslaw (1). However, it was not until 1985,
prompted by the outbreak of listeriosis in California linked
to inadequately pasteurized soft cheese, that L. monocytoge-
nes became a major concern of the food industry. In the
United States, as a first step, the Food and Drug Adminis-
tration began monitoring dairy products for L. monocytoge-
nes. This monitoring was later expanded to include ready-to-
eat foods such as cold meat and poultry products, seafood,
and salads; strict zero-tolerance guidelines for L. monocyto-
genes in ready-to-eat foods were enforced (2). 
In France, the first control measures for L. monocytoge-
nes, including microbiologic monitoring of unprocessed and
finished products, were implemented in 1986 in plants pro-
ducing cheese for exportation to the United States (3). When
a soft cheese was shown to be the cause of a large outbreak
that occurred in Switzerland from 1983 to 1987, French
authorities enforced prevention efforts to eliminate sources
of contamination by L. monocytogenes in all cheese produc-
tion plants beginning in 1988 (4). In 1992,  Listeria control
measures were extended to include plants producing ready-
to-eat meat and meat products (5). In 1992, the investigation
of a large outbreak (279 cases) identified pork tongue in jelly
as the main vehicle of transmission and showed that cross-
contamination of other ready-to-eat meat products,
especially those sold at the delicatessen counter, amplified
transmission (6). As a result, hygiene measures at the retail
level and particularly at delicatessen counters were rein-
forced (7,8). This 1992 outbreak prompted the Ministry of
Health to issue recommendations through the public media
to immunocompromised patients, the elderly, and pregnant
women to avoid certain foods, encouraging them to consult a
physician in case of symptoms suggestive of listeriosis.
Finally, in 1993,  L. monocytogenes control measures
were extended to include all foods potentially contaminated
with L. monocytogenes (9). These control measures included
microbiologic monitoring of food products and, if L. monocy-
togenes were isolated, investigation, increased sanitation,
and plant clean-up. Foods were considered to be potentially
contaminated with L. monocytogenes if they were either raw
and did not undergo a listericidal process (such as cooking)
before being eaten, or if they were pasteurized foods that
could be contaminated during handling and that have char-
acteristics favorable to the growth of Listeria (e.g., pH, water
content, and salt concentration within certain ranges). For
some products (food for infants and toddlers, canned food) a
zero-tolerance policy was enforced. For dairy, meat, and fish
products, the standard is to have no contamination, but <100
CFU L. monocytogenes/g at the end of the product’s shelf life
can be tolerated under certain circumstances.
In the same period, the dairy corporation and meat pro-
cessing association produced video training programs to help
managers improve food hygiene understanding by educating
their employees. Several guidelines were published, in 1991
and 1992 for the dairy industry and in 1994 for the meat
product industry. Guidelines to introduce Hazard Analysis
and Monitoring of Critical Control Points (HACCP) in manu-
facturing plants were promulgated in 1992 by the meat and
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dairy industry, and software was developed to help
managers implement this method in their plants. 
We analyze trends in the incidence of listeriosis to
assess the impact of the measures described.
Material and Methods 
Case Surveillance
Data on the incidence of human listeriosis in mainland
France were obtained from three independent sources. The
first source was the National Reference Center (NRC) of list-
eriosis, to which microbiology laboratories voluntarily send
human isolates of  L. monocytogenes. The NRC was the
Microbiology Laboratory of the Medical Faculty in Nantes
from 1982 to 1992; since 1993, the Institut Pasteur in Paris
has performed this function. For patients identified by the
NRC in 1997, information on pregnancy status and underly-
ing medical conditions was obtained by contacting the
attending physician (10). 
The second source was two surveys carried out among
public hospital laboratories to estimate listeriosis incidence in
France in 1987 and 1988 (11,12). In France, general hospitals
that provide primary care are distinguished from regional
hospitals, usually university teaching hospitals, which pro-
vide primary as well as secondary care. With the rare excep-
tions of a few specialized university hospitals, all general and
regional/university hospitals have neonatal or pediatric de-
partments or both, as well as an obstetric department. 
In the retrospective surveys, all laboratories of general
and regional/university hospitals were asked to complete
case reports for all patients from whom L. monocytogenes
had been isolated in the year of the survey. Information was
collected on the site of isolation of the strain and age and sex
of the patient. In 1987, information on pregnancy status and
underlying disease, as well as clinical outcome of listeriosis,
was also recorded. For each year, the total number of cases
in France was estimated by dividing the number of cases
reported by the participating hospitals by the proportion of
beds represented by these hospitals (number of beds in par-
ticipating hospitals/total number of beds in all public hospi-
tals in France). 
The third source was a surveillance network of laborato-
ries of general and regional/university hospitals called EPI-
BAC, which has been operational since 1987 (13).
Participating laboratories complete monthly report forms
indicating all cases of bacteremia or meningitis with an iso-
late of L. monocytogenes, Streptococcus pneumoniae, Haemo-
philus influenzae, Neisseria meningitidis, or Streptococcus
groups A and B. For each case, the type of isolate and the
date of birth and sex of the patient are recorded. Until 1991,
a case was defined as an isolate. Therefore, a patient with
isolates from both blood and cerebrospinal fluid (CSF) was
reported on two separate forms as a case of bacteremia and a
case of meningitis. Since 1991, cases of listeriosis are
reported on a single form, and for each case it is noted
whether the isolate was recovered from blood or CSF. Conse-
quently, for the period 1987-1997, we cannot analyze trends
in incidence from the total number of cases, since the num-
ber of cases before 1991 would be overestimated. Therefore,
we analyzed trends in incidence from 1987 to 1997 sepa-
rately from the total number of blood isolates (whether or
not associated with an isolate from CSF) and from the total
number of CSF isolates (whether or not associated with an
isolate from blood).
For each year, the total number of cases of listeriosis in
France was estimated by dividing the number of cases
reported by the participating hospitals by the proportion of
hospital admissions in medicine departments (all nonsurgi-
cal departments) represented by these hospitals (number of
admissions in medicine departments of participating hospi-
tals/total number of admissions in medicine departments in
public hospitals in France). 
Case Definition for Surveillance
In the NRC and in the two surveys of hospital laborato-
ries, a case of listeriosis was defined as isolation of L. mono-
cytogenes from a normally sterile site or, in the case of a
newborn <7 days of age, from any site. The EPIBAC network,
which used a more restricted case definition, reported only
invasive cases with an isolate of L. monocytogenes from blood
or CSF. Patients with blood or CSF isolates represent
approximately 80% of all cases identified by laboratory sur-
veys and the NRC. Pregnancy-associated cases were defined
by the isolation of L. monocytogenes from a pregnant woman
or her fetus or newborn infant within the first 30 days of life.
A mother-infant pair (even in the case of twins) was counted
as a single case. A predisposing condition was defined as one
for which an increased risk of listeriosis had been demon-
strated in a previous study (14; manuscript in preparation).
These conditions included malignancies, chronic hemodialy-
sis, hepatic or renal failure, diabetes, HIV/AIDS, corticother-
apy, chemotherapy, and organ transplantation. 
Sensitivity of Data Sources
The number of laboratories sending isolates to the NRC
increased over time. In 1986, comparison with the number of
cases identified by a survey among hospital laboratories esti-
mated this proportion at <33% of the isolates (15). For 1997,
the sensitivity for case-detection by EPIBAC and NRC was
evaluated by the capture-recapture method (16). A total of
225 cases with L. monocytogenenes isolated from blood or
CSF were identified by one or both systems: 148 by EPIBAC,
190 by NRC, and 113 by both systems. The sensitivity for
detecting cases of bacteremia or meningitis was estimated at
76% (95% confidence interval [CI] 72-81) for NRC and 59%
(95% CI 56-63) for EPIBAC. The annual incidence of inva-
sive listeriosis in 1997 was thus estimated for NRC by divid-
ing the number of identified cases by 76%. 
Food Monitoring
In France, two ministries are responsible for monitoring
foods for  L. monocytogenes. The Ministry of Agriculture is
responsible for monitoring at the production level. In addi-
tion to inspecting sanitary conditions in processing plants,
its officers test foods bacteriologically at different phases of
production and review results of microbiologic surveillance
carried out by the producer. Until 1998, results of these tests
were not available for analysis, since the data remained at
the local level. 
The Ministry of Economy (Consumers Affairs
Directorate) conducts 2-year surveys to determine the
proportion and level of contamination of foodstuffs consid-
ered to be at risk for L. monocytogenes contamination and to
evaluate the impact of preventive efforts on the frequency ofResearch
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contamination of these foodstuffs.
The results of these surveys are
available from 1993 on (17,18). The
surveys focus on foods considered
to be at risk for  L. monocytogenes
contamination because of charac-
teristics favoring its growth; ready-
to-eat foods with a long shelf life
are of particular interest. These
high-risk foods are divided into
four categories (meat, dairy, sea-
food-fish products, and prepared
salads), which are again divided
into subcategories of food types
that are considered comparable
with respect to the likelihood of
contamination. Dairy products, for
example, are divided into subcate-
gories according to whether the
product is pasteurized; soft or hard;
ripened or fresh; made of cow, goat,
or sheep milk; or blue veined or
white mold. In the 1993-94 and 1995-96 surveys, products
from 27 subcategories of ready-to-eat foods were sampled at
the retail level so that the distribution of the subcategories
was similar in both surveys. For these ready-to-eat products,
we compared the proportion of samples within the four cate-
gories of foods that was contaminated in the periods 1993-
1994 and 1995-1996. 
Statistical Analysis
Incidence data were calculated by using the census data
estimates from Institut National de la Statistique et des
Etudes Economiques (19). For 1987 and 1997, the distribu-
tion by category of the identified patients with information
on pregnancy status and medical conditions was applied to
the total estimated annual incidence to obtain category-spe-
cific incidence rates. Changes in incidence by category were
evaluated by comparing the category-specific incidence rate
in 1987, as estimated by the 1987 hospital laboratory survey,
with the category-specific estimated incidence rate in 1997,
based on the number of isolates received by NRC. 
Since the 1987 survey used a different approach from
the 1997 study, we also analyzed the proportional reduction
in number of cases by category, from the subset of hospitals
that reported cases in both 1997 and 1987. Proportions were
compared by chi-square test with Yates correction or Fisher
exact test, as appropriate. 
Results
Incidence of Listeriosis (Figure)
EPIBAC
From 1987 to 1993 and from 1994 to 1997, participating
hospitals represented 35% and 60%, respectively, of public
hospital admissions in medicine departments in France. Par-
ticipation of regional/university hospitals was slightly but
consistently higher than that of the general hospitals: in
EPIBAC hospitals, 42% of hospital admissions were in uni-
versity/regional hospitals; the figure for the whole country is
37.5%. The number of admissions in pediatric departments
divided by the number of admissions in all medicine depart-
ments (all nonsurgical) was consistently the same (14%) in
EPIBAC hospitals and in all hospitals in France.
Using data from the EPIBAC network, we found the
annual estimated incidence of bacteremia and meningitis
due to  L. monocytogenes declined substantially, from 12.3
cases for bacteremia and 3.4 cases of meningitis per million
population in 1987 to 3.5 cases of bacteremia and 0.9 cases
for meningitis per million population in 1997, a reduction of
72% and 73%, respectively. The incidence decreased slightly
from 1987 to 1989, showed a clear decrease in 1990, and con-
tinued to diminish until 1997, with the exception of 1992,
when a large outbreak involving 279 cases occurred in
France.
The annual number of cases identified by NRC
decreased by 33% from 366 (6.3 cases/million) in 1987 to 242
(4.1 cases per million) in 1997. The trend is similar to that in
EPIBAC: a decrease was observed in 1990, followed by a
peak in 1992, and then a decrease after 1993. The number of
cases identified by the NRC in 1994-1995 was similar to the
number identified in 1988-1989, whereas the incidence esti-
mated by EPIBAC shows a 54% reduction over this period.
Hospital Laboratory Surveys 
Overall, the hospitals participating in the hospital sur-
veys represented 71% (1987) and 74% (1988) of all public
hospitals beds in France. The participation of regional/uni-
versity hospitals was higher than that of general hospitals:
in 1987 and 1988, the participating regional/university hos-
pitals represented 77% and 83%, respectively, of the
regional/university hospital beds in France; the participat-
ing general hospitals represented 67% and 70%, respec-
tively, of the general hospital beds in France. The proportion
of pregnancy-associated cases was similar in regional/uni-
versity hospitals (53%) and general hospitals (49%).
Through these surveys, the incidence of listeriosis was
estimated in 1987 at 16.7 and in 1988 at 14.9 cases/million
population. The surveys show a decrease in incidence of 11%
from 1987 to 1988, slightly higher than the 6% decrease
observed by EPIBAC over the same period. 
Figure. Annual incidence of Listeria monocytogenes bacteremia estimated by the EPIBAC laboratory
network, number of isolates received by the National Reference Center, and year of implementation
of preventive measures, France, 1987-1997.Research
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Incidence by Category of Patient 
The decrease in incidence was most prominent among
pregnant women (84%) and persons <65 years of age without
predisposing conditions (82%) (Table 1). The decrease was
less marked among elderly subjects (>65 years of age) with-
out predisposing condition (62%) and much lower among
persons with a predisposing condition (37%). Analysis of the
subset of hospitals that participated in both the 1987 and the
1997 study yielded very similar results as the analysis of the
total data set (Table 2). As a result, the relative importance
of different categories of patients changed drastically. In
1987, 51% of the cases were pregnancy associated, but in
1997 this category represented 24% (Table 1). Patients with
a predisposing condition represented only 31% of all cases in
1987 but accounted for 61% of all cases in 1997. 
Food Monitoring
In 1993-94 and in 1995-96, a total of 5,809 and 6,147
ready-to-eat products were sampled, respectively. Overall,
meat products (10.8%) and seafood-fish products (10.4%)
were contaminated more frequently than dairy products
(4.7%) and prepared salads (4.5%). However, dairy products
were more frequently contaminated at higher doses than
other products: 1.8% of dairy products were found to be con-
taminated with >100 CFU/g, compared with 0.3%, 0.5%, and
1.1% for salads, seafood/fish products, and meat products,
respectively (Table 3).
During 1993-94 and 1995-96, we observed a decrease in
the proportion of contaminated products that was greater for
products contaminated with  >100 CFU/g (38%) than for
products contaminated with <100 CFU/g (10%) (Table 4).
The decrease in the proportion of products with contamina-
tion  >100 CFU/g was 56% for dairy products and 41% for
meat products. Foods with levels of contamination <100
CFU/g decreased by 33% for prepared salads and 23% for
meat products, but no substantial change was observed for
dairy products and seafood-fish products.
Discussion
The results indicate that the incidence of invasive dis-
ease by L. monocytogenes decreased substantially from 1987
through 1997. The reduction in incidence was 72% when
estimated through the EPIBAC network and 68% when esti-
mated by comparing incidence rates from the 1987 hospital
laboratory survey and the NRC in 1997. Since the 1987 sur-
vey used a different approach from the 1997 study, the dif-
ference in sensitivity of the two approaches may have
resulted in or contributed to the reduction observed. How-
ever, analysis of the subset of hospitals that participated in
both the 1987 and 1997 studies provided comparable data
and yielded results very similar to those of the analysis of
the total data set. The number of cases identified through
the public hospital laboratory surveys also decreased from
1987 to 1988, consistent with the trend observed by the
EPIBAC network. 
Table 1. Incidence and proportion of listeriosis cases by category of patient in 1987 and 1997, France
Patient categories
Cases estimated per 1,000,000 
population Percent change % of cases
1987a 1997b % 1987a 1997b
Pregnancy-associated 8.5 1.3 -84 51 24
<65 years of age with no predisposing condition 1.7 0.3 -82 10 6
>65 years of age without predisposing condition 1.3 0.5 -62 8 9
Presence of predisposing condition 5.3 3.3 -37 31 61
Total 16.7 5.4 -68 100 100
aHospital laboratory survey. 
bNational Reference Center
Table 2. Number of listeriosis cases by category of patient in 1987 and 1997, France: comparison of results from the total data set of two surveys
and from a subset of hospitals reporting cases in both surveys
Patient category
All hospitals
Subset of hospitals reporting cases in 1987 
and 1997
Cases identified Cases identified
1987a 1997  b Percent 
changec
1987a 1997b Percent change
Pregnancy-associated 336 58 -83 166 25 -85
No predisposing condition; <65 years of age 66 13 -80 36 6 -84
Predisposing condition; >65 years of age 51 22 -57 19 8 -58
Predisposing condition 208 148 -29 112 85 -24
Total 661 241 -64 333 124 -63
aHospital laboratory survey.
bNational Reference Center.
cThe percent change in number of cases has been calculated instead of the percent change in incidence, to facilitate comparison w ith the figures from the subset
of hospitals. As a result, the figures on percent change are slightly lower than those in Table 1, which take into account the increase in the French population
during the 10-year period.Research
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Table 4. Proportion of ready-to-eat foods contaminated with Listeria monocytogenes (Lm) by food category, level of contamination, and period,
France, 1993-1996
1993-94 1995-96 Percent change (%) pa
Ready-to-eat meat products
Number of samples 1,533 1,750
% of food contaminated by Lm
 <100 CFU/gb 11 8.5 -23 0.02
>100 CFU/g 1.6 0.7 -56 0.03
Total 12.6 9.2 -28 0.003
Dairy products
Number of samples 1,695 1,846
% of food contaminated by Lm
<100 CFU/gb 3.2 2.7 -16 ns
>100 CFU/g 2.2 1.3 -41 0.03
Total 5.4 4 -26 0.03
Prepared salads
Number of samples 1,740 1,426
% of food contaminated by Lm
<100 CFU/gb 4.9 3.3 -33 0.02
>100 CFU/g 0.3 0.3 0 ns
Total 5.2 3.6 -31 0.02
Seafood–fish products
Number of samples 841 1,125
% of food contaminated by Lm
 <100 CFU/gb 9.3 11.4 +22 ns
>100 CFU/g 0.7 0.5 -29 ns
 Total 10 10.3 +18 ns
Total no. of samples 5,809 6,147
% of food contaminated by Lm
 <100 CFU/gb 6.6 5.9 -10 ns
 >100 CFU/g 1.3 0.8 -38 0.007
 Total 7.9 6.7 -16 0.008
aChi-square test with Yates correction or Fisher exact test.
bLevels of contamination <100 CFU/g but greater than zero.
Table 3. Proportion of ready-to-eat foods contaminated with Listeria monocytogenes (Lm), by food category, France, 1993-1996
Ready-to-eat meat products Dairy products Prepared salads Seafood-fish products
Number of samples 3,283 3,541 3,166 1,966
% of food contaminated by Lm
<100 CFU/ga  9.7 2.9 4.2 9.7
>100 CFU/g 1.1 1.8 0.3 0.5
Total 10.8 4.7 4.5 10.4
aLevels of contamination <100 CFU/g but greater than zero.Research
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Data on the incidence by category of patient clearly indi-
cate that the largest reduction in incidence occurred in preg-
nant women and previously healthy adults <65 years of age.
A similar observation was made in the United States from
1989 to 1993, where an overall reduction in incidence of 44%
was observed (51% in pregnancy-associated cases and 37% in
patients >50 years of age), and in England and Wales, where
the proportion of pregnancy-associated cases declined from
31%-48% between 1983 and 1989 to 8%-26% between 1990
and 1996 (2,20).
During the period that the decrease in incidence was
observed, prevention measures have been progressively
introduced by the food industry. Food monitoring data
strongly suggest that these measures have successfully
reduced the distribution of L. monocytogenes-contaminated
ready-to-eat foodstuffs. The temporal relationship between
the preventive measures, the reduction in L. monocytogenes-
contaminated foodstuffs, and the decrease in incidence sup-
ports a causal relationship. A similar temporal association of
reduction in incidence with implementation of prevention
measures was observed in the U.S. study (2). The incidence
of listeriosis per million population, much higher in 1986 in
France (14.7) than in the United States (7.3), was similar in
1997 (France 5.4; USA 4.8) (21-23). Thus, the reduction in
rate from 1986 to 1997 was much greater in France. 
Dietary recommendations for immunocompromised
patients and pregnant women to avoid certain foods may
have contributed to the decline in incidence. However, sev-
eral findings suggest that this contribution is unlikely to
have been substantial. First, although dietary recommenda-
tions were targeted only at immunocompromised persons,
the elderly, and pregnant women—never at previously
healthy adults <65 years old—an 83% reduction in incidence
was observed in this category. In addition, incidence began
to decline in the period 1987 to 1992, when prevention mea-
sures at the production level were the only steps taken to
prevent listeriosis in France.
Food monitoring data indicate that the reduction in L.
monocytogenes-contaminated products was greatest for more
heavily contaminated products, with an overall decrease of
38% for products contaminated at  >100 CFU/g, compared
with 10% for products contaminated at <100 CFU/g. The
findings that the decrease in contaminated products was
most pronounced for the more heavily contaminated prod-
ucts and that the reduction in incidence was most important
among previously healthy adults and pregnancy-associated
cases support the hypothesis that these two groups need to
be exposed to a higher infectious dose for invasive illness to
develop, as demonstrated by dose-response curves (24). This
hypothesis is consistent with the finding that, in several out-
breaks in France linked to a highly contaminated food, previ-
ously healthy adults and pregnancy-associated cases
represent a far larger proportion of cases than among spo-
radic cases of listeriosis (25,26). 
In summary, in France, the incidence of invasive disease
due to  L. monocytogenes decreased by an estimated 68%
from 1987 to 1997. The decrease started during 1987-1992,
when measures by the food industry were the only steps
taken in France to prevent listeriosis. The decrease in inci-
dence was particularly important in previously healthy
adults, not included in dietary recommendations. These find-
ings suggest that a substantial part of the decrease in illness
due to  L. monocytogenes is related to control measures
implemented at the food production level.
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